periods ended June 30, 2020 and 2019 are as follows: (Million Baht) (Million Baht) Revenue and gross margin of the Company for three-month period and six-month periods ended June 30, 2020 has dramatically
LTM 3Q18 Revenue $10.1 billion, +24% YoY, Core EBITDA margin 13.7% Core EBITDA of $409m in 3Q18, +40% YoY; $1,379m LTM 3Q18 (45% YoY) LTM 3Q18 Core EPS THB 4.49, +65% post 11.1% dilution from
leading to margin increase in all commodity products, supporting the increase in crude oil prices. All of this is translating into stronger than anticipated earnings in first half 2021. Transformation
September 25, 2017 to operate medical service concerning healthcare and esthetics under trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) for the Quarter 1 Ending 31
and its Subsidiaries Million Baht Item Quarter Change (%) 9 Months Change 3/2017 2/2017 3/2016 2/2017 3/2016 2017 2016 (%) Net profit * 8.161 8,047 8,061 1.4% 1.2% 24,513 23,547 4.1% Earnings per share
(%) Net profit * 9,347 9,028 9,194 3.5% 1.7% 18,375 18,199 1.0% Earnings per share (Baht) 4.90 4.73 4.82 3.5% 1.7% 9.63 9.53 1.0% Net interest margin 2.36% 2.48% 2.33% (0.12)% 0.03% 2.42% 2.34% 0.08% Net
phase. Overall Picture of the Bank and its Subsidiaries Million Baht Item Quarter Change (%) 9 Months Change 3/2018 2/2018 3/2017 2/2018 3/2017 2018 2017 (%) Net profit * 9,030 9,194 8,161 (1.8)% 10.6
Quarter Change (%) 1/2018 4/2017 1/2017 4/2017 1/2017 Net profit * 9,005 8,496 8,305 6.0% 8.4% Earnings per share (Baht) 4.72 4.45 4.35 6.0% 8.4% Net interest margin 2.34% 2.31% 2.35% 0.03% (0.01)% Net fees
Baht 2,202 million in Q4’2018 to Baht 2,413 million in Q1’2019 due to lower scheduled maintenance and lower expense from the seasonally peak of SG&A in Q4. • EBITDA margin in Q1’2019 was 23.5% compared
expenses 1,357.0 1,901.2 2,056.1 (544.2) (28.6) (699.1) (34.0) Profit for the period 117.2 136.9 137.2 (19.7) (14.4) (20.0) (14.6) In Q3-2021, the overall Thai economy began to improve from Q2-2021, due to